Psilocybin (Filament Health)

赛洛西宾 (Filament Health)

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NamePsilocybin (Filament Health)
Drug Alias NamePsilocinmagic mushroomsPLZ-1015PEX-010PEX010 +[7] 
ClassificationSmall molecules > Heterocyclic drugsNatural product/Extract > Plants extract
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticAdjustment DisordersDepressive Disorder, Major +[21] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFilament Health Corp
China Registration ClassN/A

Develop Information

Active CompaniesPsyence Australia Pty LtdNeoLumina Bioscience IncReset Pharmaceuticals Inc +[10] 
Inactive CompaniesCybin Therapeutics IncFilament Health LLC
Active IndicationsStress Disorders, Post-TraumaticAdjustment DisordersObsessive-Compulsive Disorder +[16] 
Inactive IndicationsDepressive Disorder, MajorDepressive DisorderMental Disorders +[5] 

Other Information

ATC CodeN/A
Related LinksN/A